Combined, our data suggest efficacy of roscovitine-mediated killing of resistant CF pathogens, but the greatest efficacy is achieved when a multi-pronged approach is utilized with CFTR modulators and cysteamine. This evidence concerns the gene CFTR and cystic fibrosis.